Granted Patent
B1
US 6,936,694 · App. 06/483,451 · Granted Aug 30, 2005
Manufacture and expression of large structural genes
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the identity and/or relative position of one or more amino acids, and in terms of one or more biological and pharmacological properties but which substantially retain other such properties.
Claims (1)
1. [Met- −1 , des-Cys 1 , des-Tyr 2 , des-Cys 3 ]IFN-γ polypeptide produced by a DNA sequence coding therefor in a transformant organism, said polypeptide having substantially the characteristics of human immune interferon.
Assignments (4)
CHANGE OF NAME
Recorded Aug 12, 2015
From: VIDARA THERAPEUTICS INTERNATIONAL PUBLIC LIMITED COMPANY
To: HORIZON PHARMA PUBLIC LIMITED COMPANY
Reel/Frame 036309/0817 →
RELEASE OF SECURITY INTEREST
Recorded Mar 17, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED; AGI THERAPEUTICS, LTD. (F/K/A AGI THERAPEUTICS PLC)
Reel/Frame 032452/0237 →
SECURITY AGREEMENT
Recorded Jun 19, 2012
From: AGI THERAPEUTICS PUBLIC LIMITED COMPANY; VIDARA THERAPEUTICS RESEARCH LIMITED
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028401/0688 →
ASSIGNMENT TRANSFER OF CERTAIN RIGHTS
Recorded Feb 6, 2004
From: AMGEN INC.
To: INTERMUNE, INC.
Reel/Frame 014954/0432 →